TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2014: $74.89M2015: $71.15M2016: $120.65M2017: $327.75M2018: $326.23M2019: $290.17M2020: $366.44M2021: $339.87M2022: $346.64M2023: $249.24M2024: $120.99M2025: $52.56M$52.56M
2014Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$52.56M-56.6%
2024$120.99M-51.5%
2023$249.24M-28.1%
2022$346.64M+2.0%
2021$339.87M-7.3%
2020$366.44M+26.3%
2019$290.17M-11.1%
2018$326.23M-0.5%
2017$327.75M+171.7%
2016$120.65M+69.6%
2015$71.15M-5.0%
2014$74.89M—